Records containing: Papillomavirus Infections
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-01-21Evaluation of Viral Load Determination and Other Biomarkers of High Risk HPV-Types as a Marker for Progression of Perianal HPV-infections in HIV-positive Men Who Have Sex With Men
-
CLINICAL_TRIALS study record update · 2015-08-13Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (GARDASIL™) Post Marketing Surveillance Protocol
-
CLINICAL_TRIALS study record update · 2014-12-22A Phase III Open-label, Safety, Tolerability and Immunogenicity Study of a 9-Valent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine Administered to 9- to 15-Year-Old Japanese Preadolescent and Adolescent Girls
-
CLINICAL_TRIALS study record update · 2014-12-22A Phase III Open-Label Clinical Trial to Study the Immunogenicity and Tolerability of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, Given Concomitantly With REPEVAX™ in Preadolescents and Adolescents (11 to 15 Year Olds)
-
CLINICAL_TRIALS study record update · 2014-06-03Evaluation of Safety and Immunogenicity of GARDASIL™ in Healthy Females Between 9 and 26 Years of Age in SubSaharan Africa
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-11-19Natural History of HPV Infections in Mid-Adult Women
-
CLINICAL_TRIALS study record update · 2013-11-19HPV Infections in Older Women
-
CLINICAL_TRIALS study record update · 2013-11-19High-Risk HPV Infections in Women Aged 25 to 65
-
CLINICAL_TRIALS study record update · 2012-10-18Predictive Modeling of Anal Dysplasia Progression in HIV
-
CLINICAL_TRIALS study record update · 2011-02-14Self-collected Swabs for HPV Testing in 18-24 Year Old Women
-
CLINICAL_TRIALS study record update · 2010-09-14An Immunogenicity and Safety Study of Gardasil (V501 (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine)) in Females 9 to 23 Years of Age in Korea
-
CLINICAL_TRIALS study record update · 2010-08-03A Placebo-Controlled, Dose-Ranging Study of Quadrivalent HPV Virus-Like Particle (VLP) Vaccine in 16- to 23-Year-Old Women
-
CLINICAL_TRIALS study record update · 2010-07-09An Immunogenicity and Safety Study of Quadrivalent HPV (Types 6, 11, 16, 18) Virus-Like Particle (VLP) Vaccine in Chinese Female Subjects Aged 9 to 45 Years and Male Subjects Aged 9 to 15 Years
-
CLINICAL_TRIALS study record update · 2010-07-05Human Papillomavirus 6/11 in the Lower Airway of Neonates
-
CLINICAL_TRIALS study record update · 2010-05-04A Safety and Immunogenicity Study of Quadrivalent HPV (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in Preadolescents and Adolescents (Base Study). A Long Term Immunogenicity, Safety, and Effectiveness Study of GARDASIL (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) Among Adolescents Who Received GARDASIL at 9-18 Years of Age (Extension Study).
-
CLINICAL_TRIALS study record update · 2009-04-14Evaluation of Safety, Tolerability and Immunogenicity of Quadrivalent HPV Vaccine in Healthy Females 9 to 15 Years of Age in India
-
CLINICAL_TRIALS study record update · 2007-08-10Trial of Male Circumcision: HIV, STD and Behavioral Effects in Men, Women and the Community